Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Incyte Biosciences Nordic AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 38,640 Less Arrow 32,752 Less Arrow 28,816
Financial expenses 9 More Arrow 45 Less Arrow 33
Earnings before taxes 1,739 Less Arrow 1,397 More Arrow 1,519
EBITDA 1,711 Less Arrow 1,545 More Arrow 1,730
Total assets 12,941 More Arrow 16,777 Less Arrow 15,956
Current assets 10,841 More Arrow 16,663 Less Arrow 15,738
Current liabilities 7,812 More Arrow 12,716 More Arrow 12,723
Equity capital 5,129 Less Arrow 4,061 Less Arrow 3,233
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 10 Less Arrow 9 Less Arrow 7

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 39.6% Less Arrow 24.2% Less Arrow 20.3%
Turnover per employee 3,864 Less Arrow 3,639 More Arrow 4,117
Profit as a percentage of turnover 4.5% Less Arrow 4.3% More Arrow 5.3%
Return on assets (ROA) 13.5% Less Arrow 8.6% More Arrow 9.7%
Current ratio 138.8% Less Arrow 131.0% Less Arrow 123.7%
Return on equity (ROE) 33.9% More Arrow 34.4% More Arrow 47.0%
Change turnover 5,888 Less Arrow 3,936 More Arrow 7,380
Change turnover % 18% Less Arrow 14% More Arrow 34%
Chg. No. of employees 1 More Arrow 2 Less Arrow 1
Chg. No. of employees % 11% More Arrow 29% Less Arrow 17%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.